The 16th World Digestive and Liver Diseases Conference (WDLDC 2025), scheduled for December 17–19, 2025, in Dubai, UAE, will bring together global experts in gastroenterology and hepatology. Among the many critical focus areas, Track 17: Gastroesophageal Reflux Disease (GERD) will shed light on innovative research, diagnostic strategies, and treatment options for this widespread condition.
GERD is more than occasional heartburn — it’s a chronic disorder that can significantly impact quality of life. At WDLDC 2025, experts will explore the underlying causes, including lower esophageal sphincter dysfunction, lifestyle triggers, and genetic factors contributing to reflux disease.
🔗 Submit your abstract here: https://digestive-liverdiseases.utilitarianconferences.com/submit-abstract
From endoscopic imaging to pH monitoring and impedance testing, diagnostic tools for GERD are evolving rapidly. This track will highlight breakthroughs that enhance accuracy and allow earlier interventions for better patient outcomes.
🔗 Submit your abstract here: https://digestive-liverdiseases.utilitarianconferences.com/submit-abstract
Delegates will gain insights into both traditional and emerging GERD therapies, including proton pump inhibitors (PPIs), endoscopic interventions, and surgical solutions. Discussions will also emphasize lifestyle modifications — diet, posture, and weight management — as vital aspects of long-term care.
🔗 Submit your abstract here: https://digestive-liverdiseases.utilitarianconferences.com/submit-abstract
Track 17 will also present exciting new research, focusing on novel drug developments, microbiome influences, and preventive strategies that promise to reshape GERD management in the years ahead.
🔗 Submit your abstract here: https://digestive-liverdiseases.utilitarianconferences.com/submit-abstract
📌 Register now: https://digestive-liverdiseases.utilitarianconferences.com/registration